MiMedx Group (NASDAQ: MDXG) reported Q2 EPS of $0.05, $0.02 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $57 million versus the consensus estimate of $56.49 million.

GUIDANCE:

MiMedx Group sees Q3 2016 EPS of $0.21-$0.23, versus the consensus of $0.09. MiMedx Group sees Q3 2016 revenue of $62-64 million, versus the consensus of $63.0 million.

For earnings history and earnings-related data on MiMedx Group (MDXG) click here.